TrialAnnals of hematology2019

High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma.

Yu Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.